Oncorus, Inc.
ONCR · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11 | $16 | $14 | $12 |
| G&A Expenses | $4 | $5 | $5 | $6 |
| SG&A Expenses | $4 | $5 | $5 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $15 | $21 | $19 | $19 |
| Operating Income | -$30 | -$21 | -$19 | -$19 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$15 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$31 | -$21 | -$20 | -$19 |
| Tax Expense | $2 | $1 | $0 | $0 |
| Net Income | -$33 | -$21 | -$20 | -$20 |
| % Margin | – | – | – | – |
| EPS | -1.28 | -0.83 | -0.77 | -0.75 |
| % Growth | -54.2% | -7.8% | -2.7% | – |
| EPS Diluted | -1.28 | -0.83 | -0.77 | -0.75 |
| Weighted Avg Shares Out | 26 | 26 | 26 | 26 |
| Weighted Avg Shares Out Dil | 26 | 26 | 26 | 26 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $2 | $1 | $1 |
| EBITDA | -$44 | -$19 | -$19 | -$19 |
| % Margin | – | – | – | – |